Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
TimesSquare Capital Management U.S. Mid Cap Growth Strategy TimesSquare Capital Management LLC | “CG Oncology Inc. is a late-stage clinical biopharmaceutical company focused on developing therapeutics to treat bladder cancer. Their lead asset, Cretostimogene (Creto) is well-positioned as a potenti” | BULL | Q1 2026 Apr 20, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.